Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore

International Journal of Infectious Diseases

Volumn 22, Issue , 2014, Pages 73-77

  Fatha, Noorul ^a   Ang, Li Wei ^a   Goh, Kee Tai ^a,b  

^a MINISTRY OF HEALTH   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

General population; Seroepidemiology; Singapore; Tropics; Varicella

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; SEROEPIDEMIOLOGY; SEROPREVALENCE; SINGAPORE; VACCINATION; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; TRENDS; UTILIZATION; VARICELLA ZOSTER VIRUS;

CHICKENPOX VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SURVEYS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SINGAPORE;

EID: 84897471159     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.10.003     Document Type: Article

References (48)

1. Quarantine and Epidemiology Department. Communicable disease surveillance in Singapore 1990-2002. Singapore: Ministry of the Environment; 1991-2003.
2. Ministry of Health. Communicable Disease Surveillance in Singapore 2003-2006. Singapore: Ministry of Health; 2004-2007.
3. Chow V.T., Wan S.S., Doraisingam S., Ling A.E. Comparative analysis of the restriction endonuclease profiles of the Dumas and Singapore strains of the varicella zoster virus. J Med Virol 1993, 40:339-342.
4. Nardone A., de Oryb F., Carton M., Cohend D., van Dammee P., Davidkin I., et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007, 25:7866-7872.
5. Koskiniemi M., Lappalainen M., Schmid D.S., Rubtcova E., Loparev V.N. Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland. Clin Vaccine Immunol 2007, 14:1057-1061.
6. van Rijckevorsel G., Damen M., Sonder G.J., van der Loeff M.F., van den Hoek A. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infect Dis 2012, 12:140-147.
7. Lam M.S., Chew S.K., Allen D.M., Monteiro E.H. Fatal varicella infections in Singapore. Singapore Med J 1993, 34:213-215.
8. Phuah H.K., Chong C.Y., Lim K.W., Cheng H.K. Complicated varicella zoster infection in 8 paediatric patients and review of literature. Singapore Med J 1998, 39:115-120.
9. Nathan S., Pang A.S., Singh Sidhu D., Lam K.S., Low J.M. Necrotising soft tissue infections as a complication of chickenpox. Singapore Med J 1995, 36:656-660.
10. Tan C.B., Chitra M., Tjia T.L., Lee B.W. Central nervous system manifestations of chicken pox-a report of two cases. Singapore Med J 1985, 26:386-388.
11. Ooi P.L., Goh K.T., Doraisingham S., Ling A.E. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health 1992, 23:22-25.
12. Ministry of Health, Singapore. Prevalence of antibody to varicella-zoster virus. Epidemiological News Bulletin 1990;16:53-4.
13. Ministry of Health, Singapore. Epidemiological surveillance of varicella-zoster virus infection in Singapore. Epidemiological News Bulletin 1996;22:61-4.
14. Ministry of Health, Singapore. Seroprevalence of varicella-zoster virus infection in Singapore. Epidemiological News Bulletin 2000;26:59-62.
15. Ministry of Health, Singapore. National Health Survey 2010. published Nov 2011. (accessed 14 May 2013). http://www.moh.gov.sg/content/dam/moh_web/Publications/Reports/2011/NHS2010%20-%20low%20res.pdf.
16. Ministry of Health, Singapore. National Health Survey 2004. published Oct 2005. (accessed 24 Mar 2014). http://www.moh.gov.sg/content/moh_web/home/Publications/Reports/2005/national_health_survey2004.html.
17. Barzaga N.G., Roxas J.R., Florese R.H. Varicella zoster virus prevalence in metro Manila, Philippines. JAMA (SE Asia) 1994, 274:S633-S635.
18. Bhattarakosol P., Chantarabul S., Pittayathikhun K., Mung-mee V., Punnarugsa V. Prevalence of anti-varicella zoster IgG antibody in undergraduate students. Asia Pac J Allergy Immunol 1996, 14:129-131.
19. Kositanont U., Wasi C., Oonsombat P., Suvatte V., Thongcharoen P. Susceptibility to varicella zoster virus in Thai children and young adults. Southeast Asian J Trop Med Public Health 1985, 16:414-420.
20. Malik Y.A., Baharin R. Prevalence of varicella zoster virus infection in Malaysia. Proceedings of the 5th International Congress on the Impact of Viral Diseases in the Developing World, 1995 1995, Johannesburg, South Africa.
21. Migasena S., Simasathien S., Desakorn V., Phonrat B., Suntharasamai P., Pitisuttitham P., et al. Seroprevalence of varicella zoster virus antibody in Thailand. Int J Infect Dis 1997, 2:26-30.
22. Ministry of Public Health, Bangkok. Annual epidemiological surveillance report 1995. Thailand: Ministry of Public Health; 1995.
23. Nassar N.T., Touma H.C. Brief report: Susceptibility of Filipino nurses to the varicella zoster virus. Infect Control 1986, 7:71-72.
24. Lee B.W. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998, 3:886-890.
25. Preblud S.R. Age-specific risks of varicella complications. Pediatrics 1981, 68:14-17.
26. Muench R., Nassim C., Niku S., Sullivan-Bolyai J.Z. Seroepidemiology of varicella. J Infect Dis 1986, 153:153-155.
27. Wharton M. The epidemiology of varicella zoster virus infections. Infect Dis Clin North Am 1996, 10:571-581.
28. Struewing J.P., Hyams K.C., Tueller J.E., Gray G.C. The risk of measles, mumps, and varicella infection among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993, 83:17-20.
29. Fairley C.K., Miller E. Varicella zoster virus epidemiology-a changing scene?. J Infect Dis 1996, 174(Suppl 3):S314-S319.
30. Eguiluz G.C., Trallero E.P., Arenzana J.M. Seroepidemiology of varicella in children from Spain. J Infect Dis 1987, 156:851.
31. Taylor-Wiedeman J., Yamashita K., Miyamura K., Yamazaki S. Varicella zoster virus prevalence in Japan: no significant change in a decade. Jpn J Med Sci Biol 1989, 42:1-11.
32. Weir R, Jennings L, Young S, Brunton C, Murdoch D. National serosurvey of vaccine preventable diseases. Wellington, New Zealand: Ministry of Health; 2009.
33. Dashraath P., Ong E.S., Lee V.J. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Ann Acad Med Singapore 2007, 36:636-641.
34. Department of Statistics, Ministry of Trade and Industry, Singapore. Census of Population 2010 Statistical Release 2: Households and Housing. pdf published Feb 2011. (accessed 14 May 2013). http://www.singstat.gov.sg/publications/publications_and_papers/cop2010/census_2010_release2/cop2010sr2.
35. Garnett G.P., Cox M.J., Bundy D.A., Didier J.M., St Catharine J. The age in infection with varicella zoster virus in St Lucia, West Indies. Epidemiol Infect 1993, 110:361-372.
36. Chang C.K., Tan H.F., Tseng H.F., Lin C.C. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan. Med Mal Infect 2007, 37:222-228.
37. Liyanage N.P., Fernando S., Malavige G.N., Mallikahewa R., Sivayogan S., Jiffry M.T., et al. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka. Indian J Med Sci 2007, 61:128-134.
38. Rice P.S. Ultra-violet radiation is responsible for the differences in global epidemiology of chickenpox and the evolution of varicella-zoster virus as man migrated out of Africa. Virol J 2011, 8:189.
39. Ministry of Health. Seroprevalence of Epstein-Barr virus infection in Singapore. Epidemiological News Bulletin 1996;22:1-3.
40. Kapsenberg J.G. Possible antigenic relationship between varicella-zoster virus and herpes-simplex virus. Arch Ges Virusforsch 1964, 15:67-73.
41. Ross C.A., Sharpe J.H., Ferry P. Antigenic relationship of varicella-zoster virus and herpes-simplex. Lancet 1965, 286:708-711.
42. Edson C.M., Hosler B.A., Respass R.A., Waters D.J., Thornley-Lawson D.A. Cross-reactivity between herpes-simplex virus glycoprotein B and a 63000 Dalton varicella-zoster virus envelope glycoprotein. J Virol 1985, 56:333-336.
43. World Health Organization. Wkly Epidemiol Rec 1992;67(16):113-120.
44. Ministry of Community Development and Sports, Singapore. Singapore social statistics in brief 2004; Available at: published 2004 (accessed May 14, 2013). http://unpan1.un.org/intradoc/groups/public/documents/APCITY/UNPAN024574.pdf.
45. Early Childhood Development Agency, Singapore. Statistics on childcare services; Available at: published Jan 2014. (accessed May 13 2013). http://www.childcarelink.gov.sg/ccls/uploads/Statistics_on_child_care%28STENT%29.pdf.
46. Luman E.T., Ching P.L., Jumaan A.O., Seward J.F. Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities. Pediatrics 2006, 117:999-1008.
47. Lu L., Wang C., Suo L., Li J., Liu W., Pang X., et al. Varicella disease in Beijing in the era of voluntary vaccination, 2007-2010. Pediatr Infect Dis J 2013, 32:e314-e318.
48. Lee M.L., Shek L.P., Ma S., Chew S.K., Chew F.T., Lee B.W. Economic burden of varicella in Singapore-a cost benefit estimate of implementation of a routine varicella vaccination. Southeast Asian J Trop Med Public Health 2004, 35:693-696.